LSTA FY 2010 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$70M+503.7% YoY

Gross Profit

$20M28.9% margin

Operating Income

-$19M-27.0% margin

Net Income

-$23M-33.4% margin

EPS (Diluted)

$-677.08

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$25M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$143M

Total Liabilities

$57M

Stockholders' Equity

$49M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$70M	$12M	+503.7%
Gross Profit	$20M	$4M	+406.6%
Operating Income	-$19M	-$26M	+27.0%
Net Income	-$23M	-$26M	+10.9%